Skip to main content
. 2022 Jan 31;14(3):1087–1109. doi: 10.18632/aging.203863

Table 3. Clinical outcome according to age group.

Age 22 to 57 years (n = 287) Age 58 to 65 years (n = 286) Age 66 to 72 years (n = 283) Age 73 to 85 years (n = 266) P value
28-day mortality 36/281 (12.8) 59/279 (21.1) 100/279 (35.8) 123/263 (46.8) <0.001
90-day mortality 46/255 (18.0) 72/251 (28.7) 120/267 (44.9) 145/242 (59.9) <0.001
In hospital mortality 43/259 (16.6) 71/256 (27.7) 113/255 (44.3) 140/252 (55.6) <0.001
ICU mortality 42/277 (15.2) 71/278 (25.5) 110/274 (40.1) 133/262 (50.8) <0.001
Length of hospital stay, days 24.0 [17.0 to 33.0] 26.0 [16.0 to 41.0] 22.0 [14.0 to 39.0] 21.5 [10.0 to 36.0] 0.008
Length of hospital stay in survivors, days 25.0 [18.5 to 35.5] 30.0 [20.0 to 46.5] 32.5 [20.3 to 49.8] 33.0 [25.8 to 52.0] <0.001
Length of ICU stay, days 15.0 [10.0 to 23.0] 17.0 [10.0 to 30.0] 16.0 [8.3 to 26.0] 14.0 [7.0 to 25.0] 0.037
Length of ICU stay in survivors, days 15.0 [10.0 to 22.8] 20.0 [12.0 to 31.0] 18.0 [10.0 to 34.0] 20.0 [13.0 to 38.0] <0.001
Ventilator-free days at day 28 13.0 [0.0 to 19.0] 4.0 [0.0 to 17.0] 0.0 [0.0 to 14.2] 0.0 [0.0 to 9.7] <0.001
Duration of ventilation, days 13.0 [9.0 to 21.0] 15.0 [9.0 to 26.0] 15.0 [8.0 to 24.0] 13.0 [6.0 to 22.0] 0.023
Duration of ventilation in survivors, days* 13.0 [8.0 to 21.2] 17.0 [10.0 to 28.3] 17.0 [10.0 to 31.0] 19.0 [12.0 to 34.0] <0.001
Tracheostomy* 35/283 (12.4) 62/284 (21.8) 48/280 (17.1) 45/265 (17.0) 0.029
Reintubation* 32/282 (11.3) 42/284 (14.8) 33/278 (11.9) 33/264 (12.5) 0.631
Pneumothorax* 2/283 (0.7) 3/275 (1.1) 2/267 (0.7) 2/259 (0.8) 0.970
Thrombotic complications*& 72/287 (25.1) 95/286 (33.2) 74/283 (26.1) 78/266 (29.3) 0.135
Pulmonary embolism 55/287 (19.2) 75/286 (26.2) 61/283 (21.6) 58/266 (21.8) 0.236
Deep vein thrombosis 17/287 (5.9) 20/286 (7.0) 9/283 (3.2) 11/266 (4.1) 0.156
Ischemic stroke 3/287 (1.0) 10/286 (3.5) 8/283 (2.8) 10/266 (3.8) 0.148
Myocardial infarction 2/287 (0.7) 0/286 (0.0) 7/283 (2.5) 7/266 (2.6) 0.007
Systemic arterial thrombosis 1/287 (0.3) 1/286 (0.3) 2/283 (0.7) 0/266 (0.0) 0.805
Acute kidney injury* 89/287 (31.0) 140/285 (49.1) 126/281 (44.8) 141/265 (53.2) <0.001
Need for renal replacement* 35/287 (12.2) 62/286 (21.7) 57/283 (20.1) 51/266 (19.2) 0.013
Adjunctive therapies refractory hypoxemia** 162/284 (57.0) 174/282 (61.7) 159/282 (56.4) 152/265 (57.4) 0.563
Prone positioning 156/284 (54.9) 169/282 (59.9) 155/282 (55.0) 145/265 (54.7) 0.533
Alveolar recruitment maneuver 15/242 (6.2) 16/239 (6.7) 18/239 (7.5) 15/214 (7.0) 0.946
Other adjunctive therapies** 156/287 (54.4) 134/286 (46.9) 143/283 (50.5) 104/266 (39.1) 0.003
Neuromuscular blocking agents 156/287 (54.4) 133/286 (46.5) 141/283 (49.8) 104/266 (39.1) 0.003
Extracorporeal membrane oxygenation 7/285 (2.5) 2/282 (0.7) 2/278 (0.7) 1/262 (0.4) 0.142

Data presented as median with interquartile range [25th to 75th quartile] or n (%). Totals are different due to missing data. *Assessed at day 28. **Assessed in the first four days of ventilation. &One could have more than one thrombotic complication. Total numbers are different because of missing or unmeasured values.

ICU, Intensive Care Unit.